MGO One Seven’s BioTelemetry, Inc. BEAT Stock Holding History

MGO One Seven’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-748	Closed	-$44K	–	1963
2018 Q4	$44K	Buy	+748	New	+$44.9K	0.02%	665

Other funds holding BEAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

MGO One Seven's BEAT Position: Q1 2019 in Review

MGO One Seven sold out of BioTelemetry, Inc. (BEAT) in Q1 2019, closing a stake of 748 shares — an estimated $44K sold.

MGO One Seven first reported a position in BEAT in Q4 2018 and held it in 1 quarter. The position peaked at $44K in Q4 2018. 311 funds tracked by Wall St. Rank hold BEAT as of Q1 2019.

MGO One Seven reported no remaining BioTelemetry, Inc. position as of Q1 2019 after selling out during the quarter.
MGO One Seven sold 748 BioTelemetry, Inc. shares in Q1 2019, an estimated $44K.
MGO One Seven first reported a position in BioTelemetry, Inc. in Q4 2018 and held it in 1 quarter.
MGO One Seven's BioTelemetry, Inc. position peaked at $44K in Q4 2018.
311 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2019.

Based on MGO One Seven's 13F filing for Q1 2019, filed 9 Apr 2019.